Scarsdale, NY, United States of America

Hakim Djaballah

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Hakim Djaballah: Innovator in Cancer Research

Introduction

Hakim Djaballah is a prominent inventor based in Scarsdale, NY (US), known for his significant contributions to the field of cancer research. With a total of 11 patents to his name, he has made remarkable strides in developing innovative treatments for proliferative disorders.

Latest Patents

One of his latest patents focuses on CDC7 kinase inhibitors and their uses. This invention provides compounds, methods, pharmaceutical compositions, and kits aimed at treating proliferative disorders such as cancer. The methods involve compounds that inhibit the activity of protein kinases, specifically targeting cell division cycle (Cdc) kinase. Additionally, the invention includes compounds that inhibit Cdc7 and/or Dbf4 activity, showcasing their anti-proliferative properties. Notable compounds associated with this patent include granaticin A, granaticin B, dihydrogranaticin A, dihydrogranaticin B, medermycin, and actinorhodin.

Career Highlights

Hakim Djaballah is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research and innovations in cancer treatment. His work has been instrumental in developing new therapeutic strategies that target specific cellular mechanisms involved in cancer progression.

Collaborations

Throughout his career, Djaballah has collaborated with esteemed colleagues, including Mark G. Frattini and Thomas Joseph Kelly. These partnerships have fostered a collaborative environment that enhances the research and development of effective cancer therapies.

Conclusion

Hakim Djaballah's contributions to cancer research through his innovative patents and collaborations highlight his commitment to improving treatment options for patients. His work continues to pave the way for advancements in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…